Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase

Xiao-Tao Wang1, Veronica M S Lam, Paul C Engel

  • 1Department of Biochemistry, University of Hong Kong, Sassoon Road, Pokfulam, Hong Kong SAR, China.

Human Mutation
|August 10, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise training promotes neurogenesis in the adult hippocampus with a particular focus on cell cycle regulation.

Frontiers in sports and active living·2026
Same author

Rare Case of Acute Pulmonary Thromboembolism After Internal Fixation of Multiple Rib Fractures.

Clinical case reports·2025
Same author

Analysis of the impact of immunotherapy efficacy and safety in patients with gastric cancer and liver metastasis.

World journal of gastrointestinal surgery·2024
Same author

Green Dialysis Effluent and Plasma.

The New England journal of medicine·2024
Same author

Effect of laparoscopic sleeve gastrectomy on related variables of obesity complicated with polycystic ovary syndrome.

World journal of gastrointestinal surgery·2023
Same author

Rare blue-green urine due to excess indomethacin: A case report.

Nephrology (Carlton, Vic.)·2023

Two glucose 6-phosphate dehydrogenase (G6PD) mutants, Union and Andalus, show decreased catalytic efficiency and altered substrate binding, contributing to hemolytic anemia. Their kinetic and stability changes do not fully explain differing clinical classifications.

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Genetics

Background:

  • Glucose 6-phosphate dehydrogenase (G6PD) deficiency is a common genetic disorder leading to hemolytic anemia.
  • Clinical variants of G6PD are classified based on severity, but the molecular basis for these classifications is not always clear.
  • Specific mutations in G6PD can affect enzyme activity, stability, and substrate interactions.

Purpose of the Study:

  • To investigate the biochemical and kinetic properties of two clinical G6PD mutants, Union (p.Arg454Cys) and Andalus (p.Arg454His).
  • To determine how these mutations, which disrupt a salt bridge, impact enzyme function and stability.
  • To correlate the observed molecular changes with clinical classifications and disease phenotype.

Main Methods:

  • Construction and expression of recombinant G6PD mutants.

Related Experiment Videos

  • Purification of wild-type and mutant G6PD enzymes.
  • Kinetic studies using varying substrate concentrations (G6P, NADP+) and alternative substrates.
  • Enzyme stability assays, including thermostability measurements.
  • Analysis of enzyme kinetics to determine kinetic parameters (kcat, Km) and binding affinities.
  • Main Results:

    • Both Union and Andalus mutants exhibited a 10-fold decrease in kcat and a 90% reduction in WHO assay activity.
    • Km values for G6P and NADP+ were decreased approximately 5-fold, indicating tighter substrate binding.
    • Mutations led to several-fold tighter binding of G6P to the free enzyme, but with less productive catalysis.
    • Thermostability was moderately decreased at 37°C with NADP+.
    • Decreased catalytic efficiency contributed to the disease phenotype, explaining leukocyte G6PD levels but not erythrocyte levels.

    Conclusions:

    • The Union and Andalus G6PD mutants exhibit significantly impaired catalytic efficiency and altered substrate binding.
    • While enzyme stability is moderately affected, it does not fully account for the observed clinical severity.
    • The kinetic alterations are a major contributor to the disease phenotype, but do not fully justify the distinct clinical classifications of these mutants.
    • Further research may be needed to elucidate the precise mechanisms underlying differential G6PD variant classification.